Remicade Biosimilar Market : Global Industry Analysis 2016 - 2025 and Opportunity Assessment 2026 - 2036

Future Market Insights

Remicade Biosimilar Market

Key Insight

Demand for Remicade biosimilar will increase through 2036, with rheumatoid arthritis at a 43.2% share as the leading indication segment. The market value stood at USD 2.3 billion in 2025 and is forecast to reach USD 4.1 billion by 2036 across key growth regions including China, India, and Germany.

June 18, 2026

Anurag Sharma

250 Pages

Cite this Report

Remicade Biosimilar Market

https://www.futuremarketinsights.com/reports/remicade-biosimilar-market

License

Buy Now

Summary ToC Infographics Companies

Key Players

Amgen
Aurobindo Pharma
Bio-Thera Solutions Ltd
Celltrion Healthcare
Fresenius Kabi AG
JW Pharmaceutical
Lupin
Merck KGaA
Nichi-Iko Pharmaceutical
The Vanguard Group
Reliance Life Sciences
Samsung Bioepis Co. Ltd

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Remicade Biosimilar Market

Key Players

Similar Industry Reports